MiRNAs in Lung Adenocarcinoma: Role, Diagnosis, Prognosis, and Therapy

Int J Mol Sci. 2023 Aug 27;24(17):13302. doi: 10.3390/ijms241713302.

Abstract

Lung cancer has emerged as a significant public health challenge and remains the leading cause of cancer-related mortality worldwide. Among various types of lung malignancies, lung adenocarcinoma (LUAD) stands as the most prevalent form. MicroRNAs (miRNAs) play a crucial role in gene regulation, and their involvement in cancer has been extensively explored. While several reviews have been published on miRNAs and lung cancer, there remains a gap in the review regarding miRNAs specifically in LUAD. In this review, we not only highlight the potential diagnostic, prognostic, and therapeutic implications of miRNAs in LUAD, but also present an inclusive overview of the extensive research conducted on miRNAs in this particular context.

Keywords: LUAD; diagnosis; miRNA; oncogenic; prognosis; therapy; tumor suppressor.

Publication types

  • Review

MeSH terms

  • Adenocarcinoma of Lung* / diagnosis
  • Adenocarcinoma of Lung* / genetics
  • Adenocarcinoma of Lung* / therapy
  • Humans
  • Lung Neoplasms* / diagnosis
  • Lung Neoplasms* / genetics
  • Lung Neoplasms* / therapy
  • MicroRNAs* / genetics
  • Public Health

Substances

  • MicroRNAs

Grants and funding

This research received no external funding.